|Bid||57.24 x 100|
|Ask||57.25 x 600|
|Day's Range||56.85 - 57.34|
|52 Week Range||56.85 - 73.41|
|PE Ratio (TTM)||2.24|
|Forward Dividend & Yield||2.72 (4.69%)|
|1y Target Est||N/A|
Shares of British American Tobacco pl.c. (LSE:BATS) will begin trading ex-dividend in 3 days. To qualify for the dividend check of £0.49 per share, investors must have owned the sharesRead More...
Sweet smelling “vape” shops that sell electronic cigarettes and vapers puffing out clouds of fragrant white smoke have become common sights on UK high streets. As traditional cigarette smoking has become ...
Today we’re going to take a look at the well-established British American Tobacco pl.c. (LSE:BATS). The company’s stock received a lot of attention from a substantial price movement on theRead More...
A strong jobs report out of the U.S. boosted European shares on Friday after a sluggish start to trading, while U.S. tariffs on steel and aluminium hit steelmakers. It was strong wage growth last month that fanned speculation of faster rate rises in the United States, causing a rout in the bond market and hammering world equities.
Children in 21 countries are being exposed to promotions by tobacco companies, with cigarettes and advertising appearing close to schools
WINSTON-SALEM, N.C. (AP) — Reynolds American Inc. is giving most of its 5,500 employees a $1,000 bonus and keeping more than 99 percent of its earnings windfall from corporate tax reductions.
British American Tobacco's weaker than expected 2017 sales growth and progress on next-generation products combined to send its shares down more than 4 percent on Thursday. The company, whose brands include Dunhill and Lucky Strike cigarettes, is throwing itself into the fiercely competitive battleground of alternatives such as e-cigarettes and devices that heat tobacco without burning it, but it trails rival Philip Morris International on tobacco-heating devices that some see as more appealing to smokers. BAT said that next-generation products contributed 500 million pounds of revenue in 2017, which was below analysts' expectation of 550 million.
Harry W. Hartford of Causeway Capital Management looks for special opportunities in downtrodden stocks. By Phil van Doorn.
Four tobacco companies operating in France manipulated tests to conceal the real level of nicotine and tar contained in cigarettes, endangering the lives of smokers, a French anti-smoking organisation alleged in a legal complaint. The allegations by the National Committee Against Smoking (CNCT) target the French branches of Philip Morris, British American Tobacco, Japan Tobacco and Imperial Brands Plc.
The size of British American Tobacco plc (LSE:BATS), a £108.88B large-cap, often attracts investors seeking a reliable investment in the stock market. One reason being its ‘too big to fail’Read More...
Altria Group Inc (NYSE:MO) could have had a better quarter, but they also could have had a worse The cigarette maker is successfully “doing more with less,” between the smoking-cessation headwind and impending exit of CEO Marty Barrington. Altria remains a leader in its respective market, but it’s a market with a dim future. For the quarter ending in December, Altria Group turned $6.1 billion worth of revenue and net-revenues (net of excise taxes) of $4.7 billion into an operating profit of 91 cents per share.
As of January 30, Philip Morris International (PM) was trading at $107.94. Analysts were expecting the company’s stock price to reach $122.73 in the next 12 months, which represents a return potential of 13.7%. Before the announcement of the company’s 3Q17 earnings, analysts had forecasted a 12-month target price of $122.41.
An advisory committee to the U.S. Food and Drug Administration recently voted to reject a claim from a company that its tobacco-heating product be marketed as "reduced risk" during a review process Reynolds American Inc. also started in December 2017, but no applications for the marketing of "reduced risk" products have yet to be accepted in the U.S. The Tobacco Products Scientific Advisory Committee voted 5-4 to reject a claim by Phillip Morris that “switching completely to IQOS presents less risk of harm than continuing to smoke cigarettes,” thus recommending to the FDA that it issue the same ruling.